ArticleFrontiers in medicine2025
From endoscopy to surgery: a translational perspective on early esophageal cancer management.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The management of early-stage esophageal cancer remains suboptimal due to fragmented coordination between endoscopic and surgical modalities, resulting in diagnostic delays and inconsistent therapeutic decision-making. This study presents an integrated clinical framework that synergizes advanced endoscopic techniques (endoscopic submucosal dissection, endoscopic mucosal resection) with thoracic surgical interventions, supported by multimodal staging protocols to improve diagnostic accuracy by approximately 20%. A key innovation is the implementation of a streamlined 72-h clinical pathway, which reduces treatment delays through real-time multidisciplinary collaboration and intraoperative risk stratification using machine learning-based predictive models. To address systemic barriers, the framework incorporates competency-based cross-disciplinary training programs and value-based reimbursement structures, targeting a 28.7% reduction in treatment discrepancies. Future advancements focus on molecular stratification and health economic evaluations to further refine precision oncology approaches. This paradigm shift from sequential to integrated care demonstrates potential to enhance both oncologic outcomes and healthcare resource utilization in early esophageal cancer management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.